JP7097433B2 - 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法 - Google Patents
宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法 Download PDFInfo
- Publication number
- JP7097433B2 JP7097433B2 JP2020505786A JP2020505786A JP7097433B2 JP 7097433 B2 JP7097433 B2 JP 7097433B2 JP 2020505786 A JP2020505786 A JP 2020505786A JP 2020505786 A JP2020505786 A JP 2020505786A JP 7097433 B2 JP7097433 B2 JP 7097433B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- galectin
- matrix
- poi
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762546558P | 2017-08-17 | 2017-08-17 | |
| US62/546,558 | 2017-08-17 | ||
| PCT/US2018/046919 WO2019036626A1 (en) | 2017-08-17 | 2018-08-17 | PROCESS FOR PURIFYING GLYCOSYLATED PROTEIN FROM GALECTINES AND OTHER HOST CELL CONTAMINANTS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531411A JP2020531411A (ja) | 2020-11-05 |
| JP2020531411A5 JP2020531411A5 (cg-RX-API-DMAC7.html) | 2022-05-09 |
| JP7097433B2 true JP7097433B2 (ja) | 2022-07-07 |
Family
ID=63684424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505786A Active JP7097433B2 (ja) | 2017-08-17 | 2018-08-17 | 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11358983B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3668985B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7097433B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102578087B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111344410B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3067735A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3668985T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2887046T3 (cg-RX-API-DMAC7.html) |
| MY (1) | MY199833A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019036626A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY199833A (en) | 2017-08-17 | 2023-11-24 | Just Evotec Biologics Inc | Method of purifying glycosylated protein from host cell galectins and other contaminants |
| IL309560B2 (en) * | 2019-12-06 | 2025-05-01 | Regeneron Pharma | Anti-VEGF protein preparations and methods for their production |
| MX2022013812A (es) | 2020-05-08 | 2022-12-15 | Regeneron Pharma | Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer. |
| US20250215417A1 (en) * | 2022-03-30 | 2025-07-03 | Ionis Pharmaceuticals, Inc. | Methods for Separating Certain Oligonucleotide Compounds |
| TW202502843A (zh) * | 2023-03-17 | 2025-01-16 | 日商丸善石油化學股份有限公司 | 聚合物之製造方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008543868A (ja) | 2005-06-17 | 2008-12-04 | ワイス | Fc領域含有タンパク質を精製する方法 |
| JP2010516651A (ja) | 2007-01-17 | 2010-05-20 | メルク セローノ ソシエテ アノニム | Fc含有タンパク質の精製のための方法 |
| JP2011530606A (ja) | 2008-08-14 | 2011-12-22 | メルク・シャープ・エンド・ドーム・コーポレイション | プロテインaアフィニティークロマトグラフィーを用いる抗体の精製方法 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| ATE135045T1 (de) | 1988-07-23 | 1996-03-15 | Delta Biotechnology Ltd | Sekretorische leader-sequenzen |
| WO1990003430A1 (en) | 1988-09-23 | 1990-04-05 | Cetus Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| AT403989B (de) | 1996-09-16 | 1998-07-27 | Immuno Ag | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels |
| ES2293661T3 (es) | 1996-11-27 | 2008-03-16 | Genentech, Inc. | Purificacion por afinidad de polipeptido en una matriz de proteinas a. |
| US6022952A (en) | 1998-04-01 | 2000-02-08 | University Of Alberta | Compositions and methods for protein secretion |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| JP4475814B2 (ja) | 1998-11-20 | 2010-06-09 | 扶桑薬品工業株式会社 | タンパク質発現ベクターとその使用 |
| CA2368068A1 (en) | 1999-03-18 | 2000-09-21 | Steven M. Ruben | 27 human secreted proteins |
| US7303746B2 (en) | 1999-06-08 | 2007-12-04 | Regeneron Pharmaceuticals, Inc. | Methods of treating eye disorders with modified chimeric polypeptides |
| CN101433715B (zh) | 1999-06-08 | 2013-04-17 | 里珍纳龙药品有限公司 | 具有改善的药物动力学特性的修饰嵌合多肽 |
| US7306799B2 (en) | 1999-06-08 | 2007-12-11 | Regeneron Pharmaceuticals, Inc. | Use of VEGF inhibitors for treatment of eye disorders |
| US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| EP1472275B1 (en) | 2002-02-05 | 2008-12-17 | Genentech, Inc. | Protein purification |
| US7427659B2 (en) | 2003-10-24 | 2008-09-23 | Amgen Inc. | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| FR2894146B1 (fr) | 2005-12-07 | 2008-06-06 | Ifremer | Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus a des fins d'ingenierie des tissus conjonctifs non mineralises |
| US8263750B2 (en) | 2006-03-16 | 2012-09-11 | Amgen Inc. | Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step |
| US7998927B2 (en) | 2006-06-23 | 2011-08-16 | Aegis Therapeutics, Llc | Stabilizing alkylglycoside compositions and methods thereof |
| CL2008002054A1 (es) | 2007-07-17 | 2009-05-29 | Hoffmann La Roche | Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico. |
| CA2932207A1 (en) | 2008-10-20 | 2010-12-09 | Abbvie Inc. | Isolation and purification of antibodies using protein a affinity chromatography |
| CN105646643A (zh) | 2008-10-29 | 2016-06-08 | 阿布林克斯公司 | 单域抗原结合性分子的纯化方法 |
| WO2011038894A1 (en) | 2009-10-01 | 2011-04-07 | F. Hoffmann-La Roche Ag | Protein a chromatography |
| NZ599100A (en) * | 2009-10-20 | 2014-07-25 | Abbvie Inc | Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography |
| BR112012014937B1 (pt) | 2009-12-18 | 2021-01-19 | Novartis Ag | método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade |
| WO2012078376A1 (en) | 2010-12-08 | 2012-06-14 | Amgen Inc. | Ion exchange chromatography in the presence of an amino acid |
| TW201823460A (zh) | 2012-05-29 | 2018-07-01 | 美商再生元醫藥公司 | 生產細胞株增強子 |
| WO2015189832A1 (en) * | 2014-06-13 | 2015-12-17 | Lupin Limited | Process for the purification of tnfr:fc fusion protein |
| EP3236772A4 (en) * | 2014-12-22 | 2018-10-17 | Alexion Pharmaceuticals, Inc. | Methods of purifying recombinant proteins |
| TW201702380A (zh) * | 2015-02-27 | 2017-01-16 | 再生元醫藥公司 | 宿主細胞蛋白質修飾 |
| EP3294775B1 (en) | 2015-05-12 | 2021-07-14 | Regeneron Pharmaceuticals, Inc. | Multimeric protein purity determination |
| CN106749660B (zh) * | 2016-12-27 | 2020-02-14 | 嘉和生物药业有限公司 | 单克隆抗体下游纯化过程中有效去除宿主蛋白的方法 |
| MY199833A (en) | 2017-08-17 | 2023-11-24 | Just Evotec Biologics Inc | Method of purifying glycosylated protein from host cell galectins and other contaminants |
| JP2022520793A (ja) * | 2019-02-15 | 2022-04-01 | ジャスト-エヴォテック バイオロジックス、インコーポレイテッド | 自動バイオ製造システム、施設、及びプロセス |
-
2018
- 2018-08-17 MY MYPI2019007631A patent/MY199833A/en unknown
- 2018-08-17 EP EP18778588.6A patent/EP3668985B1/en active Active
- 2018-08-17 ES ES18778588T patent/ES2887046T3/es active Active
- 2018-08-17 JP JP2020505786A patent/JP7097433B2/ja active Active
- 2018-08-17 DK DK18778588.6T patent/DK3668985T3/da active
- 2018-08-17 KR KR1020207007328A patent/KR102578087B1/ko active Active
- 2018-08-17 CN CN201880052805.7A patent/CN111344410B/zh active Active
- 2018-08-17 WO PCT/US2018/046919 patent/WO2019036626A1/en not_active Ceased
- 2018-08-17 CA CA3067735A patent/CA3067735A1/en active Pending
- 2018-08-18 US US16/630,458 patent/US11358983B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008543868A (ja) | 2005-06-17 | 2008-12-04 | ワイス | Fc領域含有タンパク質を精製する方法 |
| JP2010516651A (ja) | 2007-01-17 | 2010-05-20 | メルク セローノ ソシエテ アノニム | Fc含有タンパク質の精製のための方法 |
| JP2011530606A (ja) | 2008-08-14 | 2011-12-22 | メルク・シャープ・エンド・ドーム・コーポレイション | プロテインaアフィニティークロマトグラフィーを用いる抗体の精製方法 |
Non-Patent Citations (5)
| Title |
|---|
| Atsuhiro Kanda et al.,Scientific Reports,2015年12月09日,5:17946,p. 1-11 |
| G. Joucla et al.,Journal of Chrmatography B,2013年,Vol. 942-943,p. 126-133 |
| Kerstin A. Heyl et al.,Biochemical and Biophysical Research Communications,2016年,Vol. 479,p. 86-90 |
| Nabila Aboulaich et al.,Biotehnol. Prog.,2014年07月26日,Vol. 30, No. 5,p. 1114-1124 |
| Santosh Kumar Patnaik et al.,Glycobiology,2005年11月29日,Vol.16, No. 4,pp. 305-317 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111344410B (zh) | 2023-09-15 |
| WO2019036626A1 (en) | 2019-02-21 |
| EP3668985B1 (en) | 2021-06-16 |
| JP2020531411A (ja) | 2020-11-05 |
| DK3668985T3 (da) | 2021-09-20 |
| US20210163528A1 (en) | 2021-06-03 |
| KR20200037396A (ko) | 2020-04-08 |
| CA3067735A1 (en) | 2019-02-21 |
| KR102578087B1 (ko) | 2023-09-18 |
| ES2887046T3 (es) | 2021-12-21 |
| MY199833A (en) | 2023-11-24 |
| EP3668985A1 (en) | 2020-06-24 |
| US11358983B2 (en) | 2022-06-14 |
| CN111344410A (zh) | 2020-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7489953B2 (ja) | 精製された組み換えポリペプチドを含む方法及び組成物 | |
| JP7777114B2 (ja) | 生物活性が低下した抗体バリアントおよびアイソフォーム | |
| KR101370253B1 (ko) | 재조합 항체의 재접힘 방법 | |
| JP6979442B2 (ja) | オーバーロード/溶出クロマトグラフィー | |
| CN109937034B (zh) | 阿柏西普制剂及其用途 | |
| US11358983B2 (en) | Method of purifying glycosylated protein from host cell galectins and other contaminants | |
| EP3261720B1 (en) | Antibodies to tau and uses thereof | |
| JP7183268B2 (ja) | 等張化剤としてリジン塩を含有するアフリベルセプト製剤及びその使用 | |
| US20230073034A1 (en) | Multispecific antibodies, compositions comprising the same, and vectors and uses thereof | |
| TW202112799A (zh) | 過載層析管柱之再生方法 | |
| JP7812826B2 (ja) | 生物活性が低下した抗体バリアント | |
| WO2023108115A1 (en) | Ph-selective antibody fc domains | |
| HK40027581B (en) | Method of purifying glycosylated protein from host cell galectins and other contaminants | |
| HK40027581A (en) | Method of purifying glycosylated protein from host cell galectins and other contaminants | |
| HK40108969A (en) | Antibody variant with reduced biological activity | |
| RU2793783C1 (ru) | Способы и композиции, включающие очищенные рекомбинантные полипептиды | |
| HK40114848A (en) | Antibody variant and isoform with lowered biological activity | |
| HK40022824A (en) | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof | |
| HK40031063B (en) | Antibody variant and isoform with lowered biological activity | |
| HK40008360A (en) | Aflibercept formulations and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210324 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220128 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20220422 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220425 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220621 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220627 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7097433 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |